Journal article
Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells
Blood, Vol.81(12), pp.3343-3349
06/15/1993
DOI: 10.1182/blood.V81.12.3343.3343
PMID: 8507872
Abstract
Bispecific monoclonal antibodies (bsabs) recognizing both CD3 and a tumor antigen can redirect T-cell-mediated cytotoxicity toward cells bearing that antigen. Such bsabs have been shown to be more effective than monospecific monoclonal antibodies (MoAbs) at preventing tumor growth in animal models of B-cell malignancy. The current studies describe the production and preliminary evaluation of a bsab designed to induce the lysis of malignant human B cells by human T cells. The bsab was obtained from a hybrid-hybridoma cell line produced by fusing OKT3-secreting hybridoma cells with hybridoma cells that secrete 1D10. 1D10 is an MoAb that recognizes an antigen found on a majority of malignant human B cells that has not been detected to a significant degree on normal resting or activated lymphocytes. High performance liquid chromatography (HPLC) was used to separate bsab from monospecific antibodies that were also present in the hybrid-hybridoma antibody product. The bsab was then evaluated in vitro for its ability to induce lysis of malignant B cells by activated T cells. The bsab consistently induced extensive lysis in vitro of 1D10 (+) cells, including both cell lines and cells obtained from patients with a variety of B-cell malignancies. No such effect was seen with activated T cells alone or activated T cells with monospecific antibody. No increased lysis was seen with 1D10 (-) cell lines. The bsab also mediated lysis of malignant B cells by autologous T cells. We conclude bsab containing an OKT3 arm and a 1D10 arm can induce T-cell-mediated lysis in a manner that is both potent and specific. This supports further evaluation of this bsab as a potential immunotherapy of B-cell malignancy.
Details
- Title: Subtitle
- Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells
- Creators
- B K Link - Department of Internal Medicine, University of Iowa College of Medicine, Iowa CityG J Weiner
- Resource Type
- Journal article
- Publication Details
- Blood, Vol.81(12), pp.3343-3349
- DOI
- 10.1182/blood.V81.12.3343.3343
- PMID
- 8507872
- NLM abbreviation
- Blood
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Grant note
- HL0734415 / NHLBI NIH HHS
- Language
- English
- Date published
- 06/15/1993
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pharmaceutical Sciences and Experimental Therapeutics; Internal Medicine
- Record Identifier
- 9984094704902771
Metrics
12 Record Views